Location: Melbourne, Australia
Date: 20 - 23 June, 2018
Ncardia is delighted to be attending this year's ISSCR, the world's largest stem cell-focused meeting, where we will present / co-present a poster outlining the use of our hiPSC-derived cardiomyocytes.
- Development of standardized and quality-controlled assays for assessment of functional and structural cardiotoxicity using human iPSC-derived cardiomyocytes
- Non-Integrating RNA-based Modifications of hiPSC-derived Cardiomyocytes – Applications for Optogenetics, siRNA knockdown and dominant negative expression of mutated transcripts
Poster with collaboration partner Eppendorf AG
With our collaboration partner Eppendorf AG Bioprocess Center:
- Scalable Production of hiPSC-Derived Cardiomyocytes in Stirred-Tank Bioreactors
Drop by our booth (#55). Greg Luerman and Felix von Haniel would be delighted to meet you and tell you all about Ncardia's products and services!